- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Zydus's injectable facility in Ahmedabad received a USFDA Establishment Inspection Report (EIR) with a favorable Voluntary Action Indicated (VAI) classification. This signals successful GMP surveillance, indicating no major compliance issues and supporting continued operations.